Nephros (NEPH): Stock Price, Earnings & Key Metrics

Price

$2.88

return (12m)

p/e

54.29

p/bv

3.96

DIVIDEND YIELD

0.00%

NEPH price

Nephros

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NEPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NEPH

Valuation

P/E

54.29

Sector 20.20

Industry 34.21

P/BV

3.96

Sector 3.13

Industry 5.15

P/Revenue (PSR)

2.21

Sector 2.12

Industry 4.72

EV/EBITDA

294.85

Sector 52.95

Industry 96.79

EV/EBIT

383.30

Sector 56.74

Industry 158.57

P/EBITDA

48.68

Sector 11.30

Industry 15.97

P/EBIT

56.47

Sector 14.26

Industry 213.26

P/Total Assets

3.07

Sector 1.54

Industry 2.28

P/Net Current Assets

5.04

Sector -2.75

Industry -6.78

P/Working Capital

4.72

Sector 7.02

Industry 24.03

EPS

0.07

Sector 2.61

Industry 8.50

BVPS

0.97

Sector 21.63

Industry 64.70

Efficiency

Gross Margin

59.99%

Sector 28.17%

Industry 27.68%

EBITDA Margin

2.50%

Sector 9.38%

Industry 24.89%

EBIT Margin

1.92%

Sector 6.17%

Industry 15.19%

Operating Margin

3.56%

Sector 7.49%

Industry 20.02%

Net Profit Margins

4.08%

Sector 5.11%

Industry 13.81%

Asset Turnover

0.38

Sector 0.19

Industry 0.26

Profitability

ROE

7.29%

Sector 10.78%

Industry 36.47%

ROA

5.66%

Sector 4.48%

Industry 6.68%

ROIC

5.74%

Sector 3.57%

Industry 5.20%

Dividends

Dividend yield

0.00%

Sector 0.17%

Industry 0.69%

Payout

0.00%

Sector 6.29%

Industry 23.60%

Debt

Current Ratio

4.55

Sector 2.16

Industry 2.59

Net Debt / EBITDA

-30.92

Sector 4.03

Industry 9.66

Net Debt / EBIT

-40.20

Sector 4.10

Industry 15.83

Net Debt / Equity

-0.38

Sector 0.21

Industry 2.58

Gross Debt / Equity

0.00

Sector 0.36

Industry 2.76

Equity/Assets

0.78

Sector 0.49

Industry 0.51

Liabilities/Assets

0.22

Sector 0.47

Industry 0.49

Growth

5Y Revenue CAGR

13.17%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Nephros ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$2.88

Fair Value

$1.24

Upside Return potential.

-57.08%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals NEPH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NEPH Nephros Inc.	$2.88	51.58%	0.00%	54.29	3.96	7.29%	4.08%
ENTG Entegris Inc.	$137.44	97.98%	0.29%	79.65	5.21	6.54%	8.18%
LRCX Lam Research Corporation	$272.41	306.65%	0.32%	59.74	37.86	63.38%	30.94%
ERII Energy Recovery Inc.	$11.29	-23.92%	0.00%	22.51	2.51	11.17%	15.06%
OTIS Otis Worldwide Corp.	$81.90	-14.05%	2.32%	19.20	-5.23	-27.25%	10.11%
AOS A. O. Smith Corp.	$66.92	5.87%	2.40%	15.48	4.35	28.10%	13.84%
CARR Carrier Global Corporation	$64.67	10.72%	1.34%	44.12	4.19	9.49%	5.99%
CLWT Euro Tech Holdings Company Limited	$1.28	8.47%	0.00%	14.18	0.75	5.30%	3.07%
XYL Xylem Inc.	$129.65	20.33%	1.34%	30.78	2.69	8.74%	10.79%
ASML ASML Holding N.V.	$1,518.30	129.34%	0.46%	55.66	27.37	49.18%	30.10%
DXPE DXP Enterprises Inc.	$154.62	95.36%	0.00%	30.80	5.29	17.19%	4.27%
FLS Flowserve Corporation	$81.64	95.79%	1.25%	24.71	3.84	15.53%	7.61%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NEPH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Nephros

Nephros Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

29 years

Founded: 1997

2004

Time since IPO - 22 years

25

Employees

Nephros Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $42.35 million, with shareholders equity totaling $10.70 million.

The company employs approximately 25 people and operates in the Bens de Capital sector, within the Bens de Capital - Vários industry.

Over the past 12 months, Nephros Inc. reported $19.12 million in revenue, generating net income of $780.00 Thousand.

Key financial metrics include a P/E ratio of 54.29, a price-to-book (P/B) ratio of 3.96, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NEPH.

Market cap

$42.35 million

Net worth

$10.70 million

$10,700,000.00

Assets

$13.79 million

$13,790,000.00

Total Shares Outstanding

11.00 million

11,000,000

Average Daily Trading Volume

$20.47 Thousand

$20,468.00

Sector

Bens de Capital

Industry

Bens de Capital - Vários

NEPH

NEPH revenue and profits

Financial Results NEPH

DRAG THE FRAME TO SEE MORE DATA

NEPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BA - Boeing

$223.78 --5,34% (12M)

P/E

74.63

0.00%

ROE

37.88%

P/BV

28.27

RTX - Raytheon Technologies

$202.83 31,48% (12M)

P/E

36.54

1.41%

ROE

10.67%

P/BV

3.90

LMT - Lockheed Martin

$611.66 48,12% (12M)

P/E

24.88

2.63%

ROE

64.00%

P/BV

15.92

CAT - Caterpillar

$794.18 85,42% (12M)

P/E

43.60

0.68%

ROE

50.54%

P/BV

22.03

GD - General Dynamics

$339.94 10,57% (12M)

P/E

22.97

1.65%

ROE

16.65%

P/BV

3.82

GE - GE

$317.92 17,93% (12M)

P/E

41.15

0.44%

ROE

50.22%

P/BV

20.66

ASML - ASML Holding

$1,518.30 109,53% (12M)

P/E

55.66

0.46%

ROE

49.18%

P/BV

27.37

NOC - Northrop Grumman

$679.99 20,93% (12M)

P/E

16.40

1.78%

ROE

26.74%

P/BV

4.38